NCT02137031View on ClinicalTrials.gov

Continuous Glucose Monitoring and Metabolic Control in Children With Type 1 Diabetes

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Type 1 Diabetes Mellitus
Interventions
DEVICE

Mini Link REAL-Time Transmitter

Children used the Mini Link REAL-Time Transmitter to measure glucose continuously for a minimum of three days per week for three months.

Trial Locations (2)

L4M 6M2

Royal Victoria Hospital, Barrie

L1M 1Z5

Charles H. Best Centre, Whitby

All Listed Sponsors
lead

University of Toronto

OTHER

NCT02137031 - Continuous Glucose Monitoring and Metabolic Control in Children With Type 1 Diabetes | Biotech Hunter | Biotech Hunter